• OPEN AN ACCOUNT
Indian Indices
Sensex
73,373.15 249.32
( 0.34%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

Finolex Industries Ltd
Industry :  Plastics Products
BSE Code
ISIN Demat
Book Value()
500940
INE183A01024
97.9534505
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FINPIPE
14.95
8829.39
EPS(TTM)
Face Value()
Div & Yield %
9.52
2
1.93
 

mid india industries ltd
Oxygenta Pharmaceutical reports standalone net loss of Rs 1.70 crore in the March 2026 quarter
May 25,2026
Net Loss of Oxygenta Pharmaceutical reported to Rs 1.70 crore in the quarter ended March 2026 as against net loss of Rs 2.15 crore during the previous quarter ended March 2025. Sales rose 0.28% to Rs 49.61 crore in the quarter ended March 2026 as against Rs 49.47 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 17.57 crore in the year ended March 2026 as against net loss of Rs 10.30 crore during the previous year ended March 2025. Sales rose 3.37% to Rs 112.98 crore in the year ended March 2026 as against Rs 109.30 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales49.6149.47 0 112.98109.30 3
OPM %0.24-3.40 --13.60-9.15 -
PBDT-1.52-3.76 60 -19.86-10.47 -90
PBT-1.28-3.53 64 -22.18-14.08 -58
NP-1.70-2.15 21 -17.57-10.30 -71